StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
114
Publishing Date
2023 - 05 - 11
2
2023 - 05 - 01
2
2023 - 03 - 22
2
2023 - 03 - 09
2
2023 - 01 - 04
1
2022 - 12 - 12
1
2022 - 12 - 07
1
2022 - 12 - 02
2
2022 - 11 - 25
1
2022 - 11 - 10
3
2022 - 09 - 12
1
2022 - 09 - 06
1
2022 - 08 - 30
1
2022 - 08 - 12
1
2022 - 07 - 28
1
2022 - 07 - 27
1
2022 - 07 - 19
1
2022 - 06 - 17
3
2022 - 06 - 07
1
2022 - 05 - 18
1
2022 - 05 - 17
3
2022 - 05 - 12
4
2022 - 05 - 10
1
2022 - 05 - 06
1
2022 - 04 - 07
3
2022 - 03 - 30
2
2022 - 03 - 17
2
2022 - 03 - 15
2
2022 - 03 - 08
2
2022 - 03 - 07
2
2022 - 03 - 04
1
2022 - 01 - 19
2
2022 - 01 - 13
2
2022 - 01 - 05
2
2022 - 01 - 03
1
2021 - 11 - 10
3
2021 - 11 - 04
2
2021 - 10 - 28
1
2021 - 10 - 26
1
2021 - 10 - 21
1
2021 - 10 - 19
2
2021 - 09 - 20
1
2021 - 09 - 03
1
2021 - 08 - 12
5
2021 - 08 - 02
1
2021 - 07 - 19
1
2021 - 07 - 02
2
2021 - 06 - 29
1
2021 - 06 - 21
1
2021 - 06 - 07
3
2021 - 06 - 02
1
2021 - 05 - 27
1
2021 - 05 - 26
1
2021 - 05 - 17
1
2021 - 05 - 07
1
2021 - 05 - 06
4
2021 - 04 - 28
1
2021 - 04 - 20
1
2021 - 04 - 02
1
2021 - 03 - 30
2
Sector
Health technology
114
Tags
Acne
1
Aesthetic
1
Approval
1
Atopic dermatitis
1
Candidate
1
Care
1
Chinese
1
Conference
7
Defa14
1
Dermatitis
2
Disease
2
Drug
1
Enroll
1
Fibrosis
1
Financial
2
Financial results
4
Fmx114
1
Global
1
Granted
1
Health
1
Immunology
1
Initiated
1
Injection
1
Medical
1
N/a
114
Patent
1
Phase 2b
1
Platform
3
Pos
1
Positive
5
Potential
1
Pre-clinical
3
Preclinical
4
Presentation
16
Report
2
Results
7
S
1
Skin
2
Symposium
1
Therapeutics
21
Treatment
3
Trial
4
Update
2
Vyn201
4
Vyn202
1
Entities
Journey medical corp
4
Vyne therapeutics inc.
114
Symbols
DERM
4
VYNE
114
Exchanges
Nasdaq
114
Crawled Date
2023 - 05 - 11
2
2023 - 05 - 01
2
2023 - 03 - 22
2
2023 - 03 - 09
2
2022 - 12 - 07
1
2022 - 12 - 02
2
2022 - 11 - 25
1
2022 - 11 - 10
3
2022 - 09 - 12
1
2022 - 09 - 06
1
2022 - 08 - 30
1
2022 - 08 - 12
1
2022 - 07 - 28
1
2022 - 07 - 27
1
2022 - 07 - 19
1
2022 - 06 - 17
3
2022 - 06 - 07
1
2022 - 05 - 18
1
2022 - 05 - 17
3
2022 - 05 - 12
4
2022 - 05 - 10
1
2022 - 05 - 06
1
2022 - 04 - 07
3
2022 - 03 - 31
1
2022 - 03 - 30
1
2022 - 03 - 17
2
2022 - 03 - 16
2
2022 - 03 - 09
1
2022 - 03 - 08
1
2022 - 03 - 07
2
2022 - 03 - 04
1
2022 - 01 - 19
2
2022 - 01 - 13
2
2022 - 01 - 05
2
2022 - 01 - 03
1
2021 - 11 - 10
3
2021 - 11 - 04
2
2021 - 10 - 28
1
2021 - 10 - 26
1
2021 - 10 - 21
1
2021 - 10 - 19
2
2021 - 09 - 20
1
2021 - 09 - 03
1
2021 - 08 - 12
5
2021 - 08 - 02
1
2021 - 07 - 19
1
2021 - 07 - 02
2
2021 - 06 - 29
1
2021 - 06 - 21
1
2021 - 06 - 07
3
2021 - 06 - 02
1
2021 - 05 - 27
1
2021 - 05 - 26
1
2021 - 05 - 17
1
2021 - 05 - 07
1
2021 - 05 - 06
4
2021 - 04 - 28
1
2021 - 04 - 20
1
2021 - 04 - 02
1
2021 - 03 - 30
2
Crawled Time
00:00
4
01:00
1
10:00
1
11:00
2
12:00
7
12:20
2
12:30
5
13:00
19
13:15
3
13:20
2
13:30
1
14:00
13
14:20
1
15:00
1
15:15
1
16:00
1
17:00
2
18:00
2
20:00
2
21:00
13
22:00
23
23:00
8
Source
amplitude.com
91
beamforall.com
172
feed.businesswire.com
385
hightideinc.com
207
investor.alkermes.com
92
investors.biomarin.com
75
ir.kalvista.com
85
jaguarhealth.gcs-web.com
189
mdxhealth.com
111
spacfeed.com
9980
velodynelidar.com
233
wodrs.com
252
www.petrosharecorp.com
77
www.adnas.com
77
www.amcnetworks.com
140
www.biospace.com
30820
www.blinkcharging.com
146
www.bmt.com
124
www.brainsway.com
208
www.canalaska.com
76
www.clinuvel.com
105
www.concentrix.com
348
www.confluent.io
272
www.cumulusmedia.com
147
www.duckcreek.com
114
www.emmis.com
149
www.extremenetworks.com
527
www.fatetherapeutics.com
150
www.fda.gov
96
www.globenewswire.com
93802
www.infinera.com
88
www.innodata.com
106
www.iridium.com
93
www.izea.com
121
www.j2global.com
94
www.kopin.com
80
www.limoneira.com
373
www.lomiko.com
90
www.marchex.com
124
www.middleby.com
240
www.myfw.com
130
www.nanthealth.com
90
www.nexstar.tv
183
www.nxtenergy.com
106
www.phunware.com
202
www.prnewswire.com
69328
www.progyny.com
195
www.repay.com
81
www.rubiconproject.com
168
www.sailpoint.com
80
www.shutterstock.com
121
www.spigroups.com
87
www.steelcase.com
132
www.sutrobio.com
164
www.taylordevices.com
82
www.thehackettgroup.com
88
www.veritone.com
174
www.vynetherapeutics.com
114
www.whirlpoolcorp.com
209
www.wisekey.com
152
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
exchanges :
Nasdaq
source :
Www.vynetherapeutics.com
save search
SEC Filing: Form 4
Published:
2023-07-05
(Crawled : 21:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-36.54%
|
O:
-0.49%
H:
3.72%
C:
3.47%
SEC Filing: Form 4
Published:
2023-06-02
(Crawled : 21:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-57.87%
|
O:
-1.31%
H:
6.64%
C:
0.66%
VYNE Investor Relations Presentation
Published:
2023-05-15
(Crawled : 16:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-64.45%
|
O:
0.14%
H:
6.56%
C:
6.08%
presentation
SEC Filing: Form 10-Q
Published:
2023-05-11
(Crawled : 21:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-57.02%
|
O:
0.0%
H:
12.54%
C:
2.01%
SEC Filing: Form 8-K
Published:
2023-05-11
(Crawled : 21:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-57.02%
|
O:
0.0%
H:
12.54%
C:
2.01%
SEC Filing: Form 8-K
Published:
2023-05-01
(Crawled : 13:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-51.14%
|
O:
0.0%
H:
18.63%
C:
14.83%
VYNE Therapeutics Announces Selection of Development Candidate VYN202, a Potential Best-in-Class Oral Small Molecule BD2-Selective BET Inhibitor for the Treatment of Immuno-Inflammatory Conditions
Published:
2023-05-01
(Crawled : 12:20)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-51.14%
|
O:
0.0%
H:
18.63%
C:
14.83%
vyn202
candidate
treatment
therapeutics
potential
VYNE Investor Relations Presentation
Published:
2023-04-20
(Crawled : 12:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-42.38%
|
O:
-7.17%
H:
9.9%
C:
5.8%
presentation
VYNE Therapeutics Announces Positive Preclinical Data for Inhaled Formulation of VYN201 in an In Vivo Model of Idiopathic Pulmonary Fibrosis
Published:
2023-04-19
(Crawled : 13:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-17.89%
|
O:
7.03%
H:
50.75%
C:
33.13%
vyn201
positive
fibrosis
preclinical
therapeutics
SEC Filing: Form 4
Published:
2023-04-04
(Crawled : 22:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-13.18%
|
O:
-1.01%
H:
6.83%
C:
-2.43%
VYNE Investor Relations Presentation
Published:
2023-03-30
(Crawled : 12:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-0.96%
|
O:
2.5%
H:
13.53%
C:
13.53%
presentation
SEC Filing: Form 4
Published:
2023-03-22
(Crawled : 21:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-5.17%
|
O:
-0.74%
H:
0.37%
C:
-5.95%
VYNE Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammation Disease Virtual Conference
Published:
2023-03-22
(Crawled : 13:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-5.17%
|
O:
-0.74%
H:
0.37%
C:
-5.95%
conference
disease
therapeutics
SEC Filing: Form 10-K
Published:
2023-03-14
(Crawled : 22:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
6.64%
|
O:
5.39%
H:
2.71%
C:
-5.12%
VYNE Therapeutics Reports Year-End 2022 Financial Results and Provides Business Update
Published:
2023-03-09
(Crawled : 23:00)
- vynetherapeutics.com
DERM
|
$3.425
-3.25%
-3.36%
60K
|
|
126.67%
|
O:
-3.33%
H:
6.9%
C:
3.45%
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-16.01%
|
O:
-1.31%
H:
1.32%
C:
-0.66%
therapeutics
financial
update
results
SEC Filing: Form 8-K
Published:
2023-03-09
(Crawled : 22:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-16.01%
|
O:
-1.31%
H:
1.32%
C:
-0.66%
VYNE Investor Relations Presentation
Published:
2023-03-01
(Crawled : 14:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-22.94%
|
O:
-1.05%
H:
0.0%
C:
-9.7%
presentation
SEC Filing: Form 8-K
Published:
2023-02-28
(Crawled : 22:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-23.28%
|
O:
-0.37%
H:
0.97%
C:
-0.08%
VYNE Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference
Published:
2023-02-22
(Crawled : 13:20)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-25.07%
|
O:
-0.29%
H:
1.39%
C:
-0.88%
care
conference
health
therapeutics
VYNE Therapeutics Announces Positive Results from Phase 1a Single and Multiple Ascending Dose Trial for Investigational Novel BET Inhibitor VYN201
Published:
2023-02-15
(Crawled : 14:00)
- vynetherapeutics.com
VYNE
|
$2.65
14.22%
12.45%
380K
|
Health Technology
|
-26.57%
|
O:
2.0%
H:
11.48%
C:
-1.68%
vyn201
trial
therapeutics
positive
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.